Itron Inc (ITRI)
Official siteTECHNOLOGY • SCIENTIFIC & TECHNICAL INSTRUMENTS • NASDAQ
Market Cap: $4.21B
Last updated: Nov 17, 2026 at 11:06 AM ET
Itron Inc (ITRI) Financials: Revenue, Profit and Cash Flow
Itron reported revenue of $2.37B for the fiscal year ended Dec 31, 2025, down 3.0% from the year before. That year, net income was $303.33M with a net margin of 12.8%, operating cash flow was $405.95M and free cash flow was $383.06M. The quarter ended Sep 30, 2026 had revenue of $599.33M and net income of $71.27M.
Revenue and Margins
The operating margin was 13.2% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $2.01B, a compound annual rate of 1.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $2.37B | -3.0% | 37.7% | 13.2% | 12.8% |
| Dec 2024 | $2.44B | +12.3% | 34.4% | 10.8% | 9.9% |
| Dec 2023 | $2.17B | +21.1% | 32.8% | 5.9% | 4.5% |
| Dec 2022 | $1.80B | -9.4% | 29.1% | -0.4% | -0.5% |
| Dec 2021 | $1.98B | -8.8% | 28.9% | -4.0% | -4.0% |
| Dec 2020 | $2.17B | -13.2% | 27.7% | -0.5% | -2.6% |
| Dec 2019 | $2.50B | +5.3% | 30.1% | 5.3% | 2.1% |
| Dec 2018 | $2.38B | +17.7% | 30.7% | -2.1% | -4.1% |
| Dec 2017 | $2.02B | +0.2% | 33.5% | 7.7% | 3.0% |
| Dec 2016 | $2.01B | N/A | 32.9% | 5.0% | 1.7% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 25.8% from the year before. In the quarter ended Sep 2026, net income rose 7.6% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.37B | $2.44B | $2.17B | $1.80B | $1.98B | $2.17B | $2.50B | $2.38B | $2.02B | $2.01B |
| Cost of revenue | $1.48B | $1.60B | $1.46B | $1.27B | $1.41B | $1.57B | $1.75B | $1.65B | $1.34B | $1.35B |
| Gross profit | $892.12M | $839.32M | $713.91M | $522.19M | $573.17M | $602.17M | $752.32M | $730.32M | $676.75M | $662.53M |
| Research and development | $207.04M | $215.03M | $208.69M | $185.10M | $197.24M | $194.10M | $202.20M | $207.91M | $169.41M | $167.77M |
| Operating income | $313.07M | $264.11M | $128.87M | -$7.44M | -$79.30M | -$10.39M | $132.68M | -$49.69M | $154.88M | $100.99M |
| Net income | $303.33M | $241.12M | $98.32M | -$9.55M | -$78.30M | -$56.88M | $52.41M | -$96.58M | $60.25M | $35.05M |
| EBITDA | $372.94M | $327.10M | $185.85M | $58.61M | $5.68M | $85.78M | $243.67M | $76.44M | $210.58M | $166.68M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $599.33M | $562.90M | $586.98M | $571.66M | $581.63M | $606.76M | $607.15M | $612.86M | $615.46M | $609.07M | $603.44M | $577.17M |
| Gross profit | $244.87M | $230.64M | $236.32M | $231.74M | $219.54M | $223.62M | $217.22M | $213.88M | $209.60M | $210.46M | $205.38M | $196.39M |
| Operating income | $95.49M | $76.07M | $67.58M | $78.66M | $81.78M | $76.41M | $76.21M | $62.73M | $73.93M | $64.65M | $62.80M | $49.27M |
| Net income | $71.27M | $53.47M | $53.59M | $103.01M | $66.22M | $68.75M | $65.35M | $58.57M | $78.91M | $51.86M | $51.79M | $44.91M |
Balance Sheet
As of Dec 2025, total debt of $1.25B exceeded cash and equivalents by $227.93M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.72B | $3.41B | $2.60B | $2.38B | $2.39B | $2.61B | $2.71B | $2.61B | $2.11B | $1.58B |
| Current assets | $1.82B | $1.82B | $1.05B | $829.58M | $749.93M | $930.26M | $997.25M | $896.14M | $849.74M | $732.47M |
| Cash and equivalents | $1.02B | $1.05B | $302.05M | $202.01M | $162.58M | $206.93M | $149.90M | $120.22M | $176.27M | $133.56M |
| Total liabilities | $1.98B | $2.00B | $1.27B | $1.19B | $1.25B | $1.77B | $1.91B | $1.87B | $1.30B | $927.46M |
| Short-term debt | $459.52M | $0 | $14.98M | $15.97M | $125.74M | $18.36M | $0 | $28.44M | $19.69M | $14.06M |
| Long-term debt | $788.80M | $1.24B | $454.83M | $452.53M | $450.23M | $902.58M | $932.48M | $988.18M | $593.57M | $290.46M |
| Shareholder equity | $1.72B | $1.39B | $1.31B | $1.17B | $1.12B | $816.55M | $776.54M | $712.66M | $786.42M | $631.60M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $4.12B | $3.99B | $3.98B | $3.72B | $3.71B | $3.62B | $3.50B | $3.41B | $3.37B | $3.28B | $2.68B | $2.60B |
| Total liabilities | $2.40B | $2.36B | $2.35B | $1.98B | $2.00B | $1.99B | $1.99B | $2.00B | $2.00B | $2.02B | $1.29B | $1.27B |
| Cash and equivalents | $840.32M | $745.23M | $712.85M | $1.02B | $1.33B | $1.22B | $1.12B | $1.05B | $982.51M | $920.64M | $300.61M | $302.05M |
| Shareholder equity | $1.70B | $1.62B | $1.61B | $1.72B | $1.69B | $1.61B | $1.49B | $1.39B | $1.35B | $1.24B | $1.36B | $1.31B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 94.4% of operating cash flow. Share repurchases came to 26.1% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $405.95M | $238.18M | $124.97M | $24.50M | $154.79M | $109.51M | $172.84M | $109.75M | $191.35M | $115.84M |
| Capital expenditures | $22.89M | $30.56M | $26.88M | $19.75M | $34.68M | $46.21M | $60.75M | $59.95M | $49.49M | $43.54M |
| Free cash flow | $383.06M | $207.61M | $98.09M | $4.75M | $120.11M | $63.31M | $112.09M | $49.80M | $141.86M | $72.30M |
| Dividends paid | N/A | N/A | N/A | N/A | $505.35M | N/A | $50.00M | N/A | $0 | $0 |
| Share repurchases | $100.00M | $100.00M | $0 | $16.97M | $8.03M | $0 | $25.00M | $0 | $0 | N/A |
| Investing cash flow | -$349.65M | -$63.41M | -$23.31M | $40.52M | -$34.88M | -$41.04M | -$48.18M | -$862.66M | -$148.18M | -$47.53M |
| Financing cash flow | -$97.46M | $579.57M | -$3.51M | -$18.74M | -$152.89M | -$11.58M | -$97.52M | $395.82M | $301.96M | -$63.02M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $101.95M | $88.09M | $85.50M | $119.32M | $117.83M | $96.69M | $72.12M | $79.85M | $65.30M | $51.72M | $41.31M | $47.90M |
| Capital expenditures | $6.41M | $6.61M | $6.53M | $7.81M | $4.42M | $6.02M | $4.64M | $9.68M | $6.62M | $7.11M | $7.14M | $8.58M |
| Free cash flow | $95.55M | $81.49M | $78.97M | $111.51M | $113.41M | $90.67M | $67.48M | $70.17M | $58.68M | $44.61M | $34.16M | $39.31M |
Frequently Asked Questions About ITRI
What is Itron's annual revenue?
Itron reported revenue of $2.37B for the fiscal year ended Dec 31, 2025.
How fast is Itron's revenue growing?
Revenue was down 3.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 9.7%.
Is Itron profitable?
Yes. Itron reported net income of $303.33M for the fiscal year ended Dec 31, 2025, with a net margin of 12.8%.
How much free cash flow does ITRI generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $405.95M minus capital expenditures of $22.89M produced free cash flow of $383.06M.
How much debt does Itron have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $788.80M, short-term debt of $459.52M and cash and equivalents of $1.02B.
ITRI pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts